Naghitorabi et al. [82] employed D-HRMA and found “CDH1 methylation” in all breast cancer tissue samples under study (n = 98, FFPE) as well as in 90% of the normal breast tissue samples (n = 10, fresh-frozen), raising serious questions about the specificity of their approach. Here, CDH1 is linked to breast carcinoma.